CDTTW CDT Equity Inc.

BEARISH Impact: 6/10 EFFECT
Horizon weeks Filed May 4, 2026 Processed 1mo ago SEC 9999999995-26-001441
IPO/offering going effective
Latest settled — T+20d
CDTTW ▲ 0.00% at T+20d
SHORT call ✗ call lost 0.00% · α vs SPY +5.65% · entry $0.006600 → $0.006600
Next anchor: T+60d in 7w
Currently $0.006600 · +0.00% from $0.006600 entry (call sign-flipped)
Entry anchored
May 4, 2026
via day open
T+1d
0.00%
call 0.00% · α +0.80%
$0.006600
settled 6w ago
T+5d
0.00%
call 0.00% · α +2.94%
$0.006600
settled 5w ago
T+20d
0.00%
call 0.00% · α +5.65%
$0.006600
settled 11d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

CDT Equity Inc.'s shelf registration (S-3, File No. 333-295226) became effective on May 1, 2026, enabling selling stockholders to resell shares registered under prior filings. This includes up to 22.8 million shares from the January 2026 S-3 and 5.3 million shares from the April 2026 S-3, creating significant dilution overhang for a micro-cap pharmaceutical company.

Actionable Insight

Monitor for trading volume spikes or Form 4 filings indicating insider/selling stockholder sales. The active shelf gives the company and selling stockholders flexibility to sell at any time, likely pressuring the stock. Watch for any announcements of takedowns under the equity line with Ascent Partners.

Key Facts

  • Effectiveness date: May 1, 2026
  • Registration statement S-3 (333-295226) declared effective
  • Prior S-3 filings registered ~22.8M shares (Jan 30, 2026) and ~5.3M shares (Apr 22, 2026) for resale
  • Selling stockholders include Ascent Partners (equity line) and others from Sarborg acquisition
  • Company will not receive proceeds from resales

Financial Impact

Up to ~28 million shares registered for resale, causing potential dilution of over 100% of current float (based on prior S-3 disclosures)

dilutionstock price

Risk Factors

  • Massive dilution from resale of registered shares
  • Continuous selling pressure from equity line draws
  • Low liquidity amplifying price impact of any sales

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001441
Document: 9999999995-26-001441-index.html9999999995-26-001441
Document: 9999999995-26-001441.txt9999999995-26-001441
3 reports for CDTTW
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CDTTW — sortable, filterable
Type Now
May 15, 2026
28d ago
8-K
NEUTRAL ★ 3/10
$0.006600 $0.006600· 0.00%▼ −1.62%$0.006600 (−0.00%)
May 4, 2026
5w ago
EFFECT
BEARISH ★ 6/10
$0.006600 $0.006600· 0.00%▲ +2.94%$0.006600 (+0.00%)
Apr 22, 2026
7w ago
S-3
BEARISH ★ 7/10
$0.006600 $0.006600· 0.00%▲ +0.05%$0.006600 (+0.00%)
Showing 3 of 3

US Market Status

Market Closed — Opens Mon (48h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access